Doctors have a new ally in keeping their patients adherent to cardiovascular medication: a urine test that can determine whether a person has taken 80 different blood pressure or cholesterol drugs in the last day or two.

New research in the New England Journal of Medicine April 5 suggests a reduction in body mass index (BMI) before puberty may decrease an individual’s risk of developing diabetes.

Both high and low concentrations of HDL cholesterol are associated with higher risks of infectious disease including gastroenteritis and pneumonia, according to new research published April 7 in the European Heart Journal.

As fitness increases, risk of cardiovascular disease (CVD) may decrease regardless of genetic predisposition, according to new findings published in Circulation on April 9.

AUSTIN, Texas, April 12, 2018 — The Janssen Pharmaceutical Companies of Johnson & Johnson today announced an additional analysis from the landmark CANVAS Program showing INVOKANA® (canagliflozin) improved renal outcomes in people with type 2 diabetes mellitus with or at high risk for cardiovascular disease.

A report issued by the Institute for Patient Access suggests commercial healthcare insurance plans, as well as Medicare, Medicaid and Medicaid managed care, denied coverage for almost 80,000 insurance claims for PCSK9 inhibitors in 2017.

To mitigate the obesity epidemic, increase workplace productivity and reduce absences, employers across the United States are engaging in employee-wide wellness programs.

Elevated blood pressure before pregnancy may increase the risk for miscarriage, according to findings published April 2 in Hypertension. This proves true for women who exhibit high blood pressure preconception but have not been diagnosed with hypertension.